CDK4 and small cell lung carcinoma: This study was to analyze the effect and molecular mechanism of Abemaciclib in inhibiting proliferation, migration and invasion of SCLC with high c-Myc expression, with a view to expanding a new direction for reducing the recurrence and metastasis.<h4>Methods</h4>Proteins interacting with CDK4/6 were predicted using the STRING database.